December 2021 – SmartLabs Announces Launch of World’s Largest Multi-Modality and Multi-Product cGMP Center for Cell and Gene Therapies in South San Francisco

December 2021 – SmartLabs Announces Launch of World’s Largest Multi-Modality and Multi-Product cGMP Center for Cell and Gene Therapies in South San Francisco

Avalon’s client, SmartLabs, has announced the launch of the World’s Largest Multi-Modality and Multi-Product cGMP Center for Cell and Gene Therapies in South San Francisco. This latest research center supports end-to-end drug development, including benchtop to 500L manufacturing that supports multiple modalities, including allogenic and autologous cell therapies. With this new announcement, SmartLabs has opened the largest footprint of end-to-end enterprise grade pharma resourcing.

For the full article, follow this (LINK).